UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cloning, expression, and characterization of the human eosinophil eotaxin receptor

The Journal of experimental medicine, 1996-05, Vol.183 (5), p.2349-2354

1996

Volltextzugriff (PDF)

Two-Site Binding of C5a by its Receptor: An Alternative Binding Paradigm for G Protein-Coupled Receptors

Proceedings of the National Academy of Sciences - PNAS, 1994-02, Vol.91 (4), p.1214-1218

1994

Volltextzugriff (PDF)

Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties

Bioorganic & medicinal chemistry letters, 2005-04, Vol.15 (8), p.2129-2134

2005

Volltextzugriff (PDF)

Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control

Molecular pharmacology, 1989-01, Vol.35 (1), p.157-163

1989

Volltextzugriff (PDF)

CCR5, CXCR4, and CD4 Are Clustered and Closely Apposed on Microvilli of Human Macrophages and T Cells

Journal of Virology, 2001-04, Vol.75 (8), p.3779-3790

2001

Volltextzugriff (PDF)

Isolation and Structure of Antagonists of Chemokine Receptor (CCR5)

Journal of natural products (Washington, D.C.), 2004-06, Vol.67 (6), p.1036-1038

2004

Volltextzugriff (PDF)

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: synthesis and structure–Activity relationships for 1-[ N-(Methyl)- N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-( N-(alkyl)- N-(benzyloxycarbonyl)amino)piperidin-1-yl)butanes

Bioorganic & medicinal chemistry letters, 2001-09, Vol.11 (18), p.2475-2479

2001

Volltextzugriff (PDF)

Characterization of ligand binding to mitochondrial benzodiazepine receptors

Molecular pharmacology, 1989-01, Vol.35 (1), p.164-172

1989

Volltextzugriff (PDF)

Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and sar study of 4-pyrazolylpiperidine side chains

Bioorganic & medicinal chemistry letters, 2004-02, Vol.14 (4), p.935-939

2004

Volltextzugriff (PDF)

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 1: Discovery and initial structure-activity relationships for 1-amino-2-phenyl-4-(piperidin-1-yl)butanes

Bioorganic & medicinal chemistry letters, 2001-01, Vol.11 (2), p.259-264

2001

Volltextzugriff (PDF)

A nonpeptidic agonist ligand of the human C5a receptor: Synthesis, binding affinity optimization and functional characterization

Bioorganic & medicinal chemistry letters, 1997-01, Vol.7 (2), p.213-218

1997

Volltextzugriff (PDF)

Combinatorial synthesis of 3-(Amidoalkyl) and 3-(Aminoalkyl)-2-arylindole derivatives: discovery of potent ligands for a variety of G-protein coupled receptors

Bioorganic & medicinal chemistry letters, 2002-01, Vol.12 (1), p.93-96

2002

Volltextzugriff (PDF)

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: Structure-activity relationships for substituted 2-aryl-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanes

Bioorganic & medicinal chemistry letters, 2001-01, Vol.11 (2), p.265-270

2001

Volltextzugriff (PDF)

1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: discovery of the pyrrolidine scaffold and determination of its stereochemical requirements

Bioorganic & medicinal chemistry letters, 2001-06, Vol.11 (11), p.1437-1440

2001

Volltextzugriff (PDF)

Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compounds

Bioorganic & medicinal chemistry letters, 2004-02, Vol.14 (4), p.941-945

2004

Volltextzugriff (PDF)

1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: lead optimization affording selective, orally bioavailable compounds with potent Anti-HIV activity

Bioorganic & medicinal chemistry letters, 2001-10, Vol.11 (20), p.2741-2745

2001

Volltextzugriff (PDF)

Combinatorial synthesis of CCR5 antagonists

Bioorganic & medicinal chemistry letters, 2001-12, Vol.11 (24), p.3137-3141

2001

Volltextzugriff (PDF)

Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection

Bioorganic & medicinal chemistry letters, 2001-12, Vol.11 (24), p.3103-3106

2001

Volltextzugriff (PDF)

Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butane

Bioorganic & medicinal chemistry letters, 2005-02, Vol.15 (4), p.977-982

2005

Volltextzugriff (PDF)

1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: Synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIV

Bioorganic & medicinal chemistry letters, 2002-10, Vol.12 (20), p.3001-3004

2002

Volltextzugriff (PDF)

Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment

Bioorganic & medicinal chemistry letters, 2004-02, Vol.14 (4), p.947-952

2004

Volltextzugriff (PDF)

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: A proposed pharmacophore model for 1-[ N-(methyl)- N-(phenylsulfonyl)amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl]butanes

Bioorganic & medicinal chemistry letters, 2001-09, Vol.11 (18), p.2469-2473

2001

Volltextzugriff (PDF)

Syntheses and SAR studies of 4-(heteroarylpiperdin-1-yl-methyl)-pyrrolidin-1-yl-acetic acid antagonists of the human CCR5 chemokine receptor

Bioorganic & medicinal chemistry letters, 2004-07, Vol.14 (13), p.3419-3424

2004

Volltextzugriff (PDF)

CCR5 antagonists: bicyclic isoxazolidines as conformationally constrained N-1-substituted pyrrolidines

Bioorganic & medicinal chemistry letters, 2002-02, Vol.12 (4), p.677-679

2002

Volltextzugriff (PDF)

1,3,4 trisubstituted pyrrolidine CCR5 receptor antagonists bearing 4-aminoheterocycle substituted piperidine side chains

Bioorganic & medicinal chemistry letters, 2003-02, Vol.13 (3), p.427-431

2003

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(44)
Tagungsberichte
(1)

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Life Sciences & Biomedicine
(32)
Biological And Medical Sciences
(31)
Medical Sciences
(27)
Pharmacology & Pharmacy
(27)
Pharmacology. Drug Treatments
(26)
Chemistry
(24)
Chemistry, Medicinal
(24)
Chemistry, Organic
(24)
Humans
(24)
Physical Sciences
(24)
Ccr5 Receptor Antagonists
(23)
Animals
(21)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(21)
Antiviral Agents
(21)
Structure-Activity Relationship
(19)
Anti-Hiv Agents - Chemical Synthesis
(15)
Anti-Hiv Agents - Pharmacology
(13)
Rats
(12)
Anti-Hiv Agents - Chemistry
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cloning, expression, and characterization of the human eosinophil eotaxin receptor

Two-Site Binding of C5a by its Receptor: An Alternative Binding Paradigm for G Protein-Coupled Receptors

Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties

Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control

CCR5, CXCR4, and CD4 Are Clustered and Closely Apposed on Microvilli of Human Macrophages and T Cells

Isolation and Structure of Antagonists of Chemokine Receptor (CCR5)

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: synthesis and structure–Activity relationships for 1-[ N-(Methyl)- N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-( N-(alkyl)- N-(benzyloxycarbonyl)amino)piperidin-1-yl)butanes

Characterization of ligand binding to mitochondrial benzodiazepine receptors

Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and sar study of 4-pyrazolylpiperidine side chains

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 1: Discovery and initial structure-activity relationships for 1-amino-2-phenyl-4-(piperidin-1-yl)butanes

A nonpeptidic agonist ligand of the human C5a receptor: Synthesis, binding affinity optimization and functional characterization

Combinatorial synthesis of 3-(Amidoalkyl) and 3-(Aminoalkyl)-2-arylindole derivatives: discovery of potent ligands for a variety of G-protein coupled receptors

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: Structure-activity relationships for substituted 2-aryl-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanes

1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: discovery of the pyrrolidine scaffold and determination of its stereochemical requirements

Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compounds

1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: lead optimization affording selective, orally bioavailable compounds with potent Anti-HIV activity

Combinatorial synthesis of CCR5 antagonists

Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection

Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butane

1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: Synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIV

Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: A proposed pharmacophore model for 1-[ N-(methyl)- N-(phenylsulfonyl)amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl]butanes

Syntheses and SAR studies of 4-(heteroarylpiperdin-1-yl-methyl)-pyrrolidin-1-yl-acetic acid antagonists of the human CCR5 chemokine receptor

CCR5 antagonists: bicyclic isoxazolidines as conformationally constrained N-1-substituted pyrrolidines

1,3,4 trisubstituted pyrrolidine CCR5 receptor antagonists bearing 4-aminoheterocycle substituted piperidine side chains

Suchergebnisse filtern